Skip to main content
. 2003 May 2;100(10):6075–6080. doi: 10.1073/pnas.1031605100

Table 4.

Characteristics of TLR2 mutations observed in white subjects with systemic meningococcal disease (n = 102 individuals and 187.2 CE examined) and normal controls (n = 104 individuals and 142.7 CE examined)

Number of chromosomes Nucleotide (genomic) Amino acid Receptor domain* Allele frequency P
Meningococcal disease
105§  726 C → T None 0.5198 0.533
  1  768 G → C None 0.0050 1.000
 15 1479 T → C None 0.0773 0.388
 13 1752 C → T None 0.0663 0.023
  2 1818 G → A None 0.0102 0.500
  2 2021 C → A P631H Cytoplasmic 0.0104 0.050
  6 2387 G → A R753Q Cytoplasmic 0.0313 1.000
Controls
 94  726 C → T None 0.5529
  8 1479 T → C None 0.0506
  3 1752 C → T None 0.0174
  8 2021 C → A P631H Cytoplasmic 0.0476
  5 2387 G → A R753Q Cytoplasmic 0.0329
*

The human TLR2 protein is 784 aa in length. Residues 1–588 are designated here as the ectodomain, residues 589–615 are assumed to span the plasma membrane, and residues 616–784 are considered to comprise the cytoplasmic domain. 

Allele frequencies refer to the number of observations divided by the number of loci that could be examined at the site in question. All coding mutations occurred in isolation from one another; i.e., no compound heterozygotes were observed. 

P value refers to the likelihood (two-sided; Fisher's exact test) that the difference between the incidence of each variant allele in the meningococcal and control populations would occur by chance. 

§

The ratio of T/T:C/T:C/C individuals among the meningococcal population was (32:30:23), whereas the ratio of T/T:C/T:C/C individuals among the control population is (25:55:21). Neither distribution represents a significant departure from predictions of the Hardy–Weinberg equilibrium.